M&A Deal Summary

Pulmatrix Acquires Pulmatrix Operating Co.

On March 16, 2015, Pulmatrix acquired life science company Pulmatrix Operating Co.

Acquisition Highlights
  • This is Pulmatrix’s 1st transaction in the Life Science sector.
  • This is Pulmatrix’s 1st transaction in the United States.
  • This is Pulmatrix’s 1st transaction in Massachusetts.

M&A Deal Summary

Date 2015-03-16
Target Pulmatrix Operating Co.
Sector Life Science
Buyer(s) Pulmatrix
Deal Type Merger
Advisor(s) Palladium Capital Group (Financial)

Target

Pulmatrix Operating Co.

Lexington, Massachusetts, United States
Pulmatrix Operating Co., Inc. is a clinical stage biotechnology company advancing a new generation of inhaled therapeutics in a novel dry powder delivery platform.

Search 214,356 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Pulmatrix

Bedford, Massachusetts, United States

Category Company
Founded 2003
Sector Life Science
Employees22
Revenue 8M USD (2024)
DESCRIPTION

Pulmatrix is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented iSPERSE technology. Pulmatrix was founded in 2003 and is based in Bedford, Massachusetts.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Merger M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2015 M&A 1 of 1